Humana Q4 Earnings Review: A Tough Quarter -- And A Rating Downgrade
Humana Inc.'s Q4 and full-year 2024 earnings report shows a 10% revenue increase but significant losses, highlighting major structural issues in its business model. Rising healthcare utilization and insufficient CMS rate increases have severely impacted Humana's profitability, with shares down 50% from their 2023 peak. New management aims to improve efficiency and service quality, but the company's future hinges on CMS rate decisions and star-rating litigation outcomes.
Is Humana dropping your Medicare Advantage plan? Here's what you need to know.
The cuts will mean turmoil and confusion for many beneficiaries, as well as the risk of higher premiums, fewer benefits or both.
Humana Incurs Wider Y/Y Loss in Q4 on Decline in Membership
HUM's fourth-quarter results suffer a blow due to a membership decline in Medicare stand-alone PDP, partly offset by a strong Primary Care business. It currently expects 2025 adjusted EPS to be around $16.25.
Humana, Inc. (HUM) Q4 2024 Earnings Call Transcript
Humana, Inc. (NYSE:HUM ) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George Renaudin - President, Insurance Conference Call Participants Ann Hynes - Mizuho Justin Lake - Wolfe Research Sarah James - Cantor Fitzgerald Joshua Raskin - Nephron Research A.J. Rice - UBS Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Erin Wright - Morgan Stanley Scott Fidel - Stephens George Hill - Deutsche Bank Ryan Langston - TD Cowen Andrew Mok - Barclays Operator Good day, and thank you for standing by.
Humana Stock Drops as Medicare Advantage Members Expected to Decline
Humana (HUM) shares slid after the health insurer said it expects Medicare Advantage memberships to decline in 2025.
Humana (HUM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
Humana (HUM) came out with a quarterly loss of $2.16 per share versus the Zacks Consensus Estimate of a loss of $2.26. This compares to loss of $0.11 per share a year ago.
Humana 2024 Profits Hit $1.2 Billion As Insurer Leaves Unprofitable Medicare Markets
Humana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter loss as the health insurer exits unprofitable Medicare Advantage markets for 2025.
Humana forecasts annual profit lower than estimates
Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its government-backed plans for older Americans would remain elevated for the rest of the year.
Humana Earnings On Deck: Investors Brace For Slower Growth Clip
Health insurance company Humana HUM is set to release its fourth-quarter 2024 earnings report on Feb. 11, before market hours. The stock has dropped 2.37% from the previous close, as of writing, on Feb.10, according to Benzinga Pro.
Will Lower Commercial Premiums Hurt Humana's Q4 Earnings?
HUM's Q4 results are likely to suffer a blow due to escalating operating costs, partly offset by membership growth in the Individual and Group Medicare Advantage business lines.
Countdown to Humana (HUM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
